Wilson Asset Management
Capitol’s healthy announcement.
On Thursday, Capitol Health (ASX: CAJ) announced its preliminary results for FY2017 reporting core radiology earnings before interest, tax, depreciation and amortisation (EBITDA) of $22.2 million, ahead of its previous guidance of $19.5-$21.5 million. The company also announced the potential for a share buyback of $52.3 million shares, upon receipt of the recently sold NSW assets. Shares in Capitol Health closed up 5% for the week. We own Capitol Health as a research-driven investment in WAM Capital, WAM Research and WAM Microcap.
Ann: Preliminary Full Year Results, page-38
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.3¢ |
Change
-0.003(0.68%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $205.7K | 561.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 215517 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 231634 | 24 |
View Market Depth
| Last trade - 13.29pm 02/12/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |
